Communicable Diseases  >>  cyclosporine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00031070: Increasing HAART-Induced Immune Restoration With Cyclosporine

Completed
2
40
US
Abacavir sulfate, Lamivudine and Zidovudine, Cyclosporine, Hepatitis A Vaccine (Inactivated), Efavirenz, Pneumococcal Conjugate Vaccine, Heptavalent, Rabies Vaccine
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
 
12/06
NCT00919451: Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy

Completed
2
16
RoW
ciclosporin
London School of Hygiene and Tropical Medicine, Homes and Hospitals of St Giles, Alert Hospital, Ethiopia, Armauer Hansen Research Institute, Ethiopia
Leprosy
06/13
07/13
NCT01938625 / 2013-002726-23: A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Checkmark ILC 2015
Apr 2015 - Apr 2015: ILC 2015
Completed
2
35
Europe
Simeprevir, Daclatasvir, Ribavirin, Cyclosporine, Tacrolimus
Janssen R&D Ireland
Hepatitis C, Chronic
04/15
07/15

Download Options